BioInvent International AB's total assets for Q4 2025 were kr671.20M, a decrease of -14.59% from the previous quarter. SE:BINV total liabilities were kr113.59M for the fiscal quarter, a 10.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.